L,-The authors have prospectively examined the occurrence of postoperative wound infection following clean neurosurgery in 936 patients. Fewer than 1% received perioperative antibiotic prophylaxis. The overall rate of deep wound infection was 2.6%; no deaths were directly attributable to these infections. Deep wound infections occurred significantly more frequently following craniotomy (4.3%) than following spinal (0.9%) or other clean neurosurgery. Among craniotomies, the deep wound infection rate varied significantly from 11% following repeat operations for recurrent gliomas to 2.5% following non-tumor surgery. Risk of deep wound infection varied more than 11-fold depending on the type of clean neurosurgical operation. It is most feasible to demonstrate the potential efficacy of perioperative antibiotics in clean neurosurgical procedures with the greatest risk of postoperative wound infection. The potential benefit from such prophylaxis would be greatest for patients undergoing these high-risk operations.
T HE use of antibiotic prophylaxis in elective neurosurgical procedures has been the focus of considerable debate. Differences in methods of identifying potential cases, definitions of infection, and designation of groups at risk have made it difficult to compare published reports of wound infection following clean neurosurgery) 8 Studies examining the effects of prophylactic antibiotics in neurosurgery have employed sequential or historical controls, 9~~ with few exceptions. 7"~6 In his review, Haines 8 concluded that information supporting antibiotic prophylaxis in neurosurgery was incomplete, and he proposed a multicenter randomized double-blind placebo-controlled trial of perioperative antibiotics for patients undergoing clean neurosurgery.
Because antibiotic prophylaxis was not routinely administered to neurosurgical patients who underwent clean elective procedures at the University of Maryland Hospital, a prospective study was performed to identify the incidence of wound infections following clean neurosurgery in risk groups that can be defined at the time of surgery. This study was also designed to determine the feasibility of a randomized controlled trial of perioperative antibiotic prophylaxis.
Clinical Material and Methods
For 30 months, all patients who underwent clean operative procedures on the neurosurgery service at the University of Maryland Hospital were studied prospectively for the development of postoperative wound infections. At this referral center, most neurosurgical admissions are housed on the neuroscience floor (three wards and one neurosurgical intensive care unit). Preoperative shaves were performed immediately prior to the procedure, and a povidone-iodine solution was used for preoperative skin preparation. With few exceptions, all surgery was performed in one of two operating rooms. During the study period, fewer than t % of the patients who underwent clean procedures received antibiotic prophylaxis.
Definition of Wound Infections
A wound infection following surgery was diagnosed if any of the following conditions were present: 1) purulence at the operative site; 2) cerebrospinal fluid (CSF) leukocytosis with nuchal rigidity, associated with a Gram stain and/or culture demonstrating the presence of microorganisms; or 3) wound infection as diagnosed by the surgeon. Postoperative wounds exhibiting signs of inflammation were monitored for the development of purulence or a surgeon's diagnosis of infection. Patients with postoperative leakage of CSF were closely observed for the development of meningitis.
Wound infections following clean neurosurgical procedures were classified as either deep or superficial. Deep craniotomy infections included involvement of the subgaleal space, bone, meninges, or neural parenchyma. Superficial infections were limited to the scalp, skin, or subcutaneous tissue surrounding the incision.
Identification of Cases
Review of wound cultures and nurse medication records for antibiotic administration were the principal methods of identifying potential cases. Each potential case was confirmed by chart review. During the 30-month period, a nurse epidemiologist visited the neurosurgical units at least weekly. Additional search for cases, to include post-discharge infections, was accomplished in periodic meetings with the neuroscience nurse practitioner. More than 90% of the patients were followed for at least 2 months after hospital discharge.
Classification of Operations
Procedures were classified as clean, clean-contaminated, contaminated-trauma, and dirty-infected according to the format of the National Academy of Sciences National Research Council. j Only clean cases were reviewed for this study. Approximately 80% of the elective neurosurgical procedures performed at the University of Maryland Hospital met criteria for a clean operation. Procedures excluded from review consisted of clean-contaminated cases (including operations using the transsphenoidal approach), contaminated cases (such as operations following gunshot wounds or for CSF leaks), and dirty cases (for example, those involving debridement of infected wounds).
Clean procedures were grouped by anatomical location: craniotomy, laminectomy, or other neurosurgery. Clean craniotomies were further subdivided, according to the indication for surgery, into: 1) tumor resection; 2) vascular repair; 3) cranioplasty; and 4) other craniotomies. Craniotomi.es for tumor resection included resection of glioblastomas, meningiomas, and epidermoid cysts. Approximately one-third of patients undergoing craniotomies for tumor resection were enrolled in the Glioma Study Group. For these patients, initial craniotomies were analyzed separately from repeat operations for recurrent tumor, because reoperation generally followed radiation therapy or combined radiation and chemotherapy. 1~ Craniotomies for vascular repair included clipping of aneurysms and evacuation of hematomas. Cranioplasties were most often for repair of congenital defects. Although some procedures involved repair of cranial defects resulting from removal of infected bone flaps, no infection was present at the time of operation. Other craniotomies most frequently involved procedures for the relief of pain. Spinal procedures were grouped by anatomical location into cervical, thoracic, and lumbosacral surgery. Other neurosurgical procedures included peripheral nerve surgery, such as carpal tunnel release and ulnar nerve repair, and carotid endarterectomy.
Methods of Analysis
For each infection, the patient's age, sex, dates of admission, type of surgery, and onset of infection were recorded. The results of all pathological cultures for each infected wound site were recorded, including organisms isolated and antibiotic susceptibilities performed by the standard disc-diffusion method? For all clean neurosurgical operations, the following information was abstracted from the operative record for each patient: diagnosis, procedure, date of procedure, operative time, and surgeons present. Summaries of infection rates were provided to the chief of Neurosurgery every 6 months for distribution to staff. 4' 5 Risk groups were compared using chi-square and Fisher's exact tests as appropriate. 6
Results
Over the 30-month study period, 936 clean neurosurgical procedures were performed. Twenty-four deep wound infections (2.6%) and 27 superficial infections (2.9%) were recorded (Table 1) . Of the 21 deep cranial infections, seven involved the subgaleal space, seven a bone flap, six the meninges, and one brain parenchyma. No deaths were directly attributable to postoperative wound infections following clean surgery. aureus infections were uniformly sensitive to gentamicin and to the anti-staphylococcal agents tested (methicillin, erythromycin, clindamycin, and cephalothin); however, three S. epidermidis were resistant to clindamycin and gentamicin, and two were resistant in addition to methicillin or erythromycin. Five Gramnegative rods were resistant to cephalothin and one to gentamicin. In the deep wound infections, 19 of the 23 organisms isolated were susceptible to methicillin and 20 were susceptible to cephalothin.
Of the 936 patients undergoing clean neurosurgery, 53% were male. The incidence of deep wound infection was 2.2% for males and 3.0% for females. For all patients, the mean age was 34 years, for those with deep wound infection the mean age was 46 years; patients in the third and seventh decades of life demonstrated the highest rates of deep wound infection: five (3.9%) of 129 and seven (4.7%) of 149, respectively. Parallel increases in rates of superficial and deep wound infection occurred with increasing duration of operation. One (0.9%) of the 116 operations lasting less than 2 hours developed deep wound infections, whereas deep wound infections occurred in 17 (4.3%) of 392 operations requiring more than 4 hours. A slight, but not statistically significant, decrease in the deep wound infection rate occurred during the study period; a significant (p < 0.05) decrease in the wound infection rate of one surgeon occurred following the first 6 months of the study.
Superficial wound infections followed approximately 3% of both cranial and spinal operations. The rate did not vary significantly with anatomical location of surgery or indication for craniotomy (Table 1 ). In contrast, deep wound infections occurred significantly (p < 0.05) more frequently following craniotomy (4.3 %) than after either spinal (0.9%) or other neurosurgical (0%) procedures (Table l) . Among craniotomies, procedures for brain tumors had the highest deep wound infection rate (6.0%). These infections were more common in the Glioma Study Group patients (9%); seven of the eight infections in these patients occurred after repeat operation ( Table 2 ). The median operating time for the Glioma Study Group patients was only 9 minutes longer than for other tumor patients. The rate of deep wound infections varied significantly (p < 0.05) from 11% in patients undergoing reoperations for glioma to 2.5% in patients undergoing craniotomies for reasons other than tumor (Table 3) .
Discussion
Several results of this study are helpful in making judgments about perioperative antibiotic prophylaxis in neurosurgery.
A penicillinase-resistant penicillin (methiciUin) or a first-generation cephalosporin (cephalothin) was effective in vitro against more than 80% of the organisms isolated from deep wound infections in our series. Problem organisms such as cephalothin-resistant Gramnegative rods and methicillin-resistant Staphylococci were involved in only three of 24 deep wound infections in this series. An elevated incidence of such organisms might require examining the efficacy of an aminoglycoside or vancomycin as a prophylactic agent. 712
Superficial infections were carefully differentiated from deep wound infections. Superficial and deep wound infections occurred with approximately equal frequency (2.9% versus 2.6%); however, superficial infections usually caused minimal morbidity, rarely involved a prolonged hospital stay, and could be treated with a simple drainage procedure or antibiotic therapy, often on an outpatient basis. Studies of the efficacy of perioperative prophylaxis should therefore be focused primarily on the prevention of deep suppuration following neurosurgery.
The deep wound infection rate of 2.6% in this study is comparable with reports summarized in previous reviews. ~~a Prophylactic antibiotics were used very infrequently. Therefore, the deep infection rates reported in this study can serve as a reasonable basis for estimating the feasibility of controlled trials of perioperative antibiotics as well as for estimating the potential benefit of such prophylaxis.
The risk of deep wound infection varied greatly t Data from present report (to nearest 0:5%). :~ One-tailed chi-square (a < 0.05;/3 > 0.8).
w Estimated efficacy (% reduction in incidence) expected for perioperative antibiotics.
according to the type of neurosurgical operation, from less than 1% in patients following spinal and other noncranial procedures to 11% in glioma patients undergoing reoperation. The data demonstrate that risk of postoperative wound infection can vary more than 11-fold for patients undergoing clean neurosurgery. Although some investigators have reported rates of infection following craniotomy to be higher than after spinal surgery, 2,j7a8 the wide variations in risk of wound infection following clean neurosurgery have not generally been appreciated. Our results imply that important differences in risk of postoperative wound infection can be defined prior to a clean neurosurgical procedure. There are important consequences. Cruse and Foord 4'5 have indicated that a clean surgical wound infection rate of 1% might be a goal for some surgical services. Our data suggest that, while a deep infection rate of 1% in spinal surgery may be a helpful benchmark, the same rate appears unlikely to be achieved in cranial tumor surgery. All clean surgery should not be considered together; operative risk can be evaluated more precisely by separating types of surgery. Controlled trials of perioperative antibiotic prophylaxis for clean neurosurgery must ensure that the patients receiving antibiotics and those receiving placebo are undergoing operations with comparable risk of infection.
A judgment on the feasibility of a placebo-controlled trial of perioperative antibiotics in neurosurgery and a projection of the potential benefit of perioperative antibiotics require the following estimates: 1) the rate of wound infections in the absence of antibiotic prophylaxis, and 2) the reduction in infection rate attributable to antibiotic prophylaxis which is expected or is thought to be important. Rates of infection are available from the present study for reoperation for recurrent glioma, for surgery on other brain tumors, for other cranial surgery, and for spinal surgery (Tables 1 and 3) . Data from a recent trial conducted by Geraghty and Feely 7 suggest that an 80% reduction in infection rate might be attributable to perioperative antimicrobial agents, but the number of infections studied was very limited.
Sample size estimates for some trials have been based on a 50% reduction in infection rate. Others may consider that a 10% reduction in deep neurosurgical wound infections associated with serious morbidity would be important. Based on these estimates, Table  4A presents the number of operations of each type required in a controlled trial to demonstrate (a < 0.05; /3 > 0.8; one-tailed chi-square) that the anticipated reduction in infection rate occurred. ~ With the assumption that the anticipated reduction in the infection rate did occur as a result of perioperative antibiotics, Table 4B presents the percent of patients undergoing each type of procedure in whom a postoperative wound infection would be prevented.
With high prophylactic efficacy (80%), a trial of prophylaxis for repeat operations on gliomas would still require 7 years at our hospital; with low efficacy (10%), even multi-center trials are not feasible. A feasible cooperative trial of perioperative antibiotic prophylaxis in 2000 patients undergoing spinal surgery and 3000 patients undergoing craniotomy (Table 4A) would likely be successful in spinal surgery patients if prophylactic efficacy were high (80%), and in craniotomy patients even if efficacy were only moderate (50%). Approximately 1% of such patients would benefit from the prophylaxis (Table 4B) . By identifying clean neurosurgical operations with the highest risk of infection, we can also define patients in whom the benefit of perioperative antibiotics is easiest to demonstrate, and for whom the benefit would be the greatest.
